Apr 3, 2024 05:30PM
Apr 3, 2024 05:30PM
Nov 1, 2022 04:01PM
Aug 4, 2022 04:01PM
May 11, 2022 04:01PM
Mar 9, 2022 04:01PM
Nov 9, 2021 04:01PM Acorda Therapeutics Reports Third Quarter 2021 Financial Results, Additions to Leadership Team
Aug 5, 2021 04:01PM
May 6, 2021 04:00PM
Mar 4, 2021 04:01PM
Nov 3, 2020 04:00PM
Aug 4, 2020 04:00PM
Jul 15, 2020 09:30AM
May 5, 2020 04:00PM Acorda Reports First Quarter 2020 Financial Results and Provides Business Update
Feb 13, 2020 07:00AM
Jan 3, 2020 09:27AM
Nov 4, 2019 04:00PM
Oct 24, 2019 09:21AM
Aug 1, 2019 04:00PM
May 2, 2019 06:00AM
Mar 8, 2019 07:00AM Acorda Therapeutics Announces Management Changes
Feb 14, 2019 04:00PM
Jan 17, 2019 06:33PM
Jan 17, 2019 06:30PM
Dec 24, 2018 05:51AM
Dec 21, 2018 09:53PM
Dec 21, 2018 09:53PM
Oct 31, 2018 06:00AM Acorda Provides Financial and Pipeline Update for Third Quarter 2018
Oct 18, 2018 09:28AM
Aug 2, 2018 06:00AM
May 2, 2018 06:00AM
Feb 15, 2018 06:00AM
Jan 19, 2018 09:29AM
Nov 20, 2017 09:31AM
Nov 20, 2017 07:08AM Acorda Therapeutics (ACOR) Ends Tozadenant Development
Nov 20, 2017 07:00AM
Nov 15, 2017 09:30AM
Oct 31, 2017 06:00AM
Aug 29, 2017 09:33AM
Aug 7, 2017 09:07AM
Jul 27, 2017 06:00AM
Apr 27, 2017 06:00AM Acorda Provides Financial and Pipeline Update for First Quarter 2017
Apr 13, 2017 07:00AM
Apr 5, 2017 06:01AM
Apr 5, 2017 06:00AM
Mar 31, 2017 12:32PM
Mar 31, 2017 12:31PM
Mar 31, 2017 12:15PM
Mar 29, 2017 06:04AM Acorda Therapeutics (ACOR) Safety Data for CVT-301 Shows No Differences in Pulmonary Function
Mar 29, 2017 06:00AM

1,160,180 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All